The current Covid-19 pandemic situation has shown that repurposing drugs can be crucial for delivering new treatments to patients with agility. Existing drugs can be developed to bring fast, safe and cost-effective treatments for a wide range of conditions. The improved use of data and the development of advanced AI-based technologies enable the fast and effective identification of drugs, accelerating drug discovery, repurposing and innovation.
SOM Biotech works with a proprietary ligand-based in-silico platform, SOMAI PRO that has proven to be an outstanding tool to successfully identify drugs with similar or better biological activity compared to a reference compound acting on a disease-related target. The drug discovery approach is fundamentally based on molecular structures, and particularly on their structural and physicochemical properties – the “molecular fields” (MFs).
Thank you.Please check your email to download the white paper.